FOSAPREPITANT MEDSURGE fosaprepitant (as dimeglumine) 150 mg powder for injection vial

Страна: Австралия

Език: английски

Източник: Department of Health (Therapeutic Goods Administration)

Активна съставка:

fosaprepitant dimeglumine, Quantity: 245.3 mg (Equivalent: fosaprepitant, Qty 150 mg)

Предлага се от:

Medsurge Pharma Pty Ltd

Лекарствена форма:

Injection, powder for

Композиция:

Excipient Ingredients: disodium edetate; polysorbate 80; hydrochloric acid; sodium hydroxide; lactose

Начин на приложение:

Intravenous Infusion

Броя в опаковка:

1 vial

Вид предписание :

(S4) Prescription Only Medicine

Терапевтични показания:

Fosaprepitant, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: ? highly emetogenic cancer chemotherapy (see Section 4.2 Dose and Method of Administration) ? moderately emetogenic cancer chemotherapy (see Section 4.2 Dose and Method of Administration).

Каталог на резюме:

Visual Identification: White-off white lyophilized cake or powder.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Статус Оторизация:

Registered